Epigenome editing in cancer: Advances and challenges for potential therapeutic options
International Review of Cell and Molecular Biology · 2024 · 191-230
DOI: 10.1016/bs.ircmb.2023.10.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Review of Cell and Molecular Biology, 2024. Verfasst von Seung-Won Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 326 Literaturangaben. Gefördert von: Knight Cancer Institute, Oregon Health and Science University, Misophonia Research Fund, Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health…
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Biomedical Engineering Graduate Program, Department of Biomedical Engineering, S…
Förderung
- Knight Cancer Institute, Oregon Health and Science University
- Misophonia Research Fund
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University
Zitieren
APA
Lee, S. W., Frankston, C. M., & Kim, J. (2024). Epigenome editing in cancer: Advances and challenges for potential therapeutic options. International Review of Cell and Molecular Biology, 191-230. https://doi.org/10.1016/bs.ircmb.2023.10.001
Vancouver
Lee SW, Frankston CM, Kim J. Epigenome editing in cancer: Advances and challenges for potential therapeutic options. International Review of Cell and Molecular Biology. 2024:191-230. doi:10.1016/bs.ircmb.2023.10.001
BibTeX
@article{Lee2024,
author = {Lee, Seung-Won and Frankston, Connor Mitchell and Kim, Jungsun},
title = {Epigenome editing in cancer: Advances and challenges for potential therapeutic options},
journal = {International Review of Cell and Molecular Biology},
year = {2024},
pages = {191--230},
doi = {10.1016/bs.ircmb.2023.10.001}
}
EUVIMED